--- title: "Managed Service / Reagent Rental, Definition | MedTech Terms" description: "Multi-year contract where instrument cost is bundled into per-test pricing. Plain-English Commercialization definition for MedTech teams, with examples and rela" lang: en json-ld: | { "@context": "https://schema.org", "@graph": [ { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/managed-service-contract#term", "name": "Managed Service / Reagent Rental", "description": "Managed service or reagent-rental contracts bundle the capital cost of an instrument into a fixed per-test or per-procedure price across a multi-year term, eliminating customer CapEx and locking in consumables share.", "url": "https://medtechterms.com/terms/managed-service-contract", "termCode": "managed-service-contract", "inDefinedTermSet": { "@type": "DefinedTermSet", "name": "MedTech Terms", "url": "https://medtechterms.com/terms" } }, { "@type": "Article", "@id": "https://medtechterms.com/terms/managed-service-contract#article", "headline": "Managed Service / Reagent Rental", "description": "Multi-year contract where instrument cost is bundled into per-test pricing.", "url": "https://medtechterms.com/terms/managed-service-contract", "mainEntityOfPage": { "@type": "WebPage", "@id": "https://medtechterms.com/terms/managed-service-contract" }, "about": { "@id": "https://medtechterms.com/terms/managed-service-contract#term" }, "articleSection": "Commercialization", "inLanguage": "en", "keywords": "Managed Service / Reagent Rental, Commercialization, medical device, MedTech", "author": { "@type": "Person", "name": "Christian Espinosa", "jobTitle": "Founder, Blue Goat Cyber", "url": "https://bluegoatcyber.com" }, "publisher": { "@type": "Organization", "name": "MedTech Terms", "url": "https://medtechterms.com" }, "isPartOf": { "@type": "WebSite", "name": "MedTech Terms", "url": "https://medtechterms.com" }, "datePublished": "2026-05-05", "dateModified": "2026-05-05", "citation": [ { "@type": "CreativeWork", "name": "ASC 842 overview", "url": "https://www.fasb.org/", "publisher": { "@type": "Organization", "name": "FASB" } }, { "@type": "CreativeWork", "name": "AdvaMed Code of Ethics", "url": "https://www.advamed.org/our-work/code-of-ethics/", "publisher": { "@type": "Organization", "name": "AdvaMed" } }, { "@type": "CreativeWork", "name": "AHRMM - Healthcare Supply Chain", "url": "https://www.ahrmm.org/", "publisher": { "@type": "Organization", "name": "AHRMM" } } ], "mentions": [ { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/razor-razorblade#term", "name": "Razor / Razor-Blade Model", "url": "https://medtechterms.com/terms/razor-razorblade" }, { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/ivd#term", "name": "In Vitro Diagnostics", "alternateName": "IVD", "url": "https://medtechterms.com/terms/ivd" } ] }, { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "Home", "item": "https://medtechterms.com/" }, { "@type": "ListItem", "position": 2, "name": "Terms", "item": "https://medtechterms.com/terms" }, { "@type": "ListItem", "position": 3, "name": "Commercialization", "item": "https://medtechterms.com/terms?cat=Commercialization" }, { "@type": "ListItem", "position": 4, "name": "Managed Service / Reagent Rental", "item": "https://medtechterms.com/terms/managed-service-contract" } ] }, { "@type": "FAQPage", "@id": "https://medtechterms.com/terms/managed-service-contract#faq", "mainEntity": [ { "@type": "Question", "name": "Does a managed service agreement change the legal manufacturer's responsibilities?", "acceptedAnswer": { "@type": "Answer", "text": "No, a managed service agreement does not alter the legal manufacturer's core responsibilities for ensuring the safety, efficacy, and quality of their medical device throughout its lifecycle, as stipulated by regulations like the EU MDR Annex I or FDA's 21 CFR Part 820." } }, { "@type": "Question", "name": "How do these agreements impact post-market surveillance?", "acceptedAnswer": { "@type": "Answer", "text": "The legal manufacturer remains responsible for post-market surveillance. The agreement should define how service providers report adverse events, performance issues, or feedback to the manufacturer for analysis and regulatory reporting, which is crucial under regulations such as 21 CFR Part 803 and EU MDR Article 83." } }, { "@type": "Question", "name": "What cybersecurity considerations apply to managed service offerings?", "acceptedAnswer": { "@type": "Answer", "text": "Cybersecurity responsibilities must be clearly delineated within the managed service contract. This includes defining who is responsible for patching, vulnerability management, access controls, and incident response, in line with FDA's " } }, { "@type": "Question", "name": "What cybersecurity considerations apply to managed service offerings?", "acceptedAnswer": { "@type": "Answer", "text": "Cybersecurity responsibilities must be clearly delineated within the managed service contract. This includes defining who is responsible for patching, vulnerability management, access controls, and incident response, in line with FDA's " } } ] } ] } --- [ MedTech Terms The authoritative reference ](/) Browse Learn [Latest](/latest) About 1. [Home](/) 2. / 3. [Terms](/terms) 4. / 5. [Commercialization](/terms?cat=Commercialization) 6. / 7. Managed Service / Reagent Rental [All terms](/terms) Commercialization [Hospital Buyer & Reimbursement](/ecosystems/hospital-buyer) # Managed Service / Reagent Rental Multi-year contract where instrument cost is bundled into per-test pricing. Reviewed by [Christian Espinosa, Founder, Blue Goat Cyber](/authors/christian-espinosa) Last reviewed May 5, 2026 ## Definition Managed service or reagent-rental contracts bundle the capital cost of an instrument into a fixed per-test or per-procedure price across a multi-year term, eliminating customer CapEx and locking in consumables share. What the regulation says Managed service and reagent rental agreements are primarily commercial constructs. Regulatory bodies like the FDA or those governing EU [MDR](/terms/mdr-reporting) focus on the safety and performance of the medical devices involved, not directly on the financial arrangements. However, the service aspect implies responsibilities for device maintenance, servicing, and potentially software updates, which are covered under quality system regulations (e.g., 21 CFR 820.200 for servicing, [ISO 13485](/terms/iso-13485):2016 clause 7.5.4 for service activities) to ensure continued compliance and patient safety. ## What this means in practice Standard in [IVD](/terms/ivd), increasingly common in imaging AI and surgical capital. Revenue recognition (ASC 842 lease vs service) requires careful structuring. ## Examples - A hospital enters into a managed service agreement for a new AI-powered diagnostic imaging system, where the vendor maintains the software, performs updates, and ensures data security. - A clinical laboratory utilizes a reagent rental agreement for an IVD analyzer, with the vendor providing the instrument and reagents, while also handling routine maintenance and calibration as part of the per-test fee. - A surgical center signs a managed service contract for robotic surgery equipment, where the manufacturer provides the robot, specialized instruments, and ongoing technical support and preventive maintenance. Common pitfalls - • Confusing the commercial contract with regulatory obligations for device servicing and maintenance. - • Failing to establish clear responsibilities for software updates and cybersecurity patching in managed service agreements. - • Assuming that the financial arrangement absolves the legal manufacturer of post-market surveillance duties. - • Neglecting to consider the impact of service level agreements on device uptime and regulatory reporting requirements. - • Improperly classifying the service under financial accounting standards (e.g., ASC 842 if a lease rather than a service) can have audit and compliance implications. ## Frequently asked questions Does a managed service agreement change the legal manufacturer's responsibilities? No, a managed service agreement does not alter the legal manufacturer's core responsibilities for ensuring the safety, efficacy, and quality of their medical device throughout its lifecycle, as stipulated by regulations like the EU [MDR](/terms/mdr-reporting) Annex I or FDA's 21 CFR Part 820. How do these agreements impact post-market surveillance? What cybersecurity considerations apply to managed service offerings? What cybersecurity considerations apply to managed service offerings? ## Related terms Grouped by theme ### Editor's picks · Hand-selected related concepts [ Commercialization Razor / Razor-Blade Model Sell capital equipment at low margin; recurring consumables drive profit. ](/terms/razor-razorblade)[ Market Segments In Vitro Diagnostics(IVD) Tests performed on biological samples outside the body. ](/terms/ivd) ### More in Commercialization · Same category [ Commercialization AdvaMed Code of Ethics Industry code governing interactions between U.S. medical-device companies and healthcare professionals. ](/terms/advamed-code)[ Commercialization Advisory Board Convening of external experts to advise on strategy or product. ](/terms/advisory-board)[ Commercialization Anti-Kickback Statute(AKS) U.S. criminal statute prohibiting remuneration to induce federal healthcare business. ](/terms/anti-kickback)[ Commercialization Bottom-Up Market Sizing Building market size from procedure volumes × price × penetration. ](/terms/bottom-up-sizing) Cited by Where this term appears across MedTech Terms. Ecosystems (1) - [Hospital Buyer & Reimbursement](/ecosystems/hospital-buyer) ## Primary references 3 sources Link health: 3 verified · last checked 2026-06-20 FASB· 1 AdvaMed· 1 AHRMM· 1 1. [1 ASC 842 overview Verified FASB · fasb.org ](https://www.fasb.org/) 2. [2 AdvaMed Code of Ethics Verified AdvaMed · advamed.org ](https://www.advamed.org/our-work/code-of-ethics/) 3. [3 AHRMM - Healthcare Supply Chain Verified AHRMM · ahrmm.org ](https://www.ahrmm.org/) Inline markers like \[1\] jump to the matching reference above. Sponsor note ### Selling a connected device into health systems? Hospital procurement increasingly requires MDS2, SBOM, and security questionnaires - we help your team answer them confidently. [Book a 30-minute discovery session](https://go.bluegoatcyber.com/meetings/blue-goat-cyber/discovery-session) - No obligation - Expert-led from minute one - NDA available on request MedTech Terms is a community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com). Definitions are independent of any vendor. On this term Category Commercialization Sources 3 Updated 5/5/2026 [Compare with another term](/compare?a=managed-service-contract) Learn in 60 seconds Card Lesson Quiz Multi-year contract where instrument cost is bundled into per-test pricing. - · Standard in IVD, increasingly common in imaging AI and surgical capital. - · Revenue recognition (ASC 842 lease vs service) requires careful structuring. Remember this Watch out: Confusing the commercial contract with regulatory obligations for device servicing and maintenance. Related terms - [Razor / Razor-Blade Model ](/terms/razor-razorblade) - [In Vitro Diagnostics(IVD) ](/terms/ivd) You may also need Auto-suggested from Commercialization and shared keywords. - [Group Purchasing Organization(GPO) ](/terms/gpo) - [Bottom-Up Market Sizing ](/terms/bottom-up-sizing) - [TAM / SAM / SOM ](/terms/tam-sam-som) - [Value Analysis Committee(VAC) ](/terms/vac) - [AAMI TIR97(TIR97) ](/terms/aami-tir97) - [Ambulatory Payment Classification(APC) ](/terms/apc) [All Commercialization terms](/terms?cat=Commercialization) MedTech Terms An authoritative, plain-language reference for the regulatory, quality, cybersecurity, and software terms that shape modern medical devices. Browse - [All terms](/terms) - [A–Z index](/a-z) - [Categories](/categories) - [Ecosystems](/ecosystems) - [Learning paths](/paths) - [Compare terms](/compare) - [Quiz](/quiz) Resources - [FDA Medical Devices](https://www.fda.gov/medical-devices) - [EU MDR](https://eur-lex.europa.eu/eli/reg/2017/745/oj) - [IMDRF](https://www.imdrf.org/) - [Methodology](/methodology) - [Changelog](/changelog) - [Editor: Christian Espinosa](/authors/christian-espinosa) - [About this site](/about) © 2026 MedTech Terms. Reference content for educational purposes - not regulatory advice. A community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com)